Cargando…
PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA
Autores principales: | Basturk, A., Bagci, M., Dal, M. S., Hacibekiroglu, T., Kabukcu Hacioglu, S., Aydogdu, I., Kizil Cakar, M., Sunu, C., Akgun Cagliyan, G., Kaya, A., Dogu, M. H., Celik, S., Uskudar Teke, H., Erkurt, M. A., Ekinci, O., Turgut, B., Tekinalp, A., Korkmaz, S., Ulas, T., Altuntas, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429689/ http://dx.doi.org/10.1097/01.HS9.0000851120.44523.52 |
Ejemplares similares
-
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
por: Yiğenoğlu, Tuğçe Nur, et al.
Publicado: (2021) -
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
por: Başcı, Semih, et al.
Publicado: (2021) -
2072. Multicenter Evaluation of the Etest vs. Agar Dilution for Susceptibility Testing of Helicobacter pylori
por: Shakir, Salika M, et al.
Publicado: (2018) -
Radiation exposure in acute myeloid leukaemia, diffuse large B-cell lymphoma, and multiple myeloma patients in the first year following diagnosis
por: Koluman, Başak Ünver, et al.
Publicado: (2023) -
2072. Clinical Evaluation of the BioFire® Global Fever Special Pathogens Panel
por: Collins, Brittany, et al.
Publicado: (2023)